UBS Group AG - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 23 filers reported holding INHIBIKASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$65
-99.1%
130
-98.3%
0.00%
Q3 2022$7,000
-12.5%
7,499
+46.7%
0.00%
Q1 2022$8,000
+166.7%
5,112
+190.6%
0.00%
Q4 2021$3,000
-81.2%
1,759
-79.4%
0.00%
Q3 2021$16,0008,5480.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders